Somatostatin potentiates cholinergic neurotransmission in ferret trachea |
| |
Authors: | K Sekizawa P D Graf J A Nadel |
| |
Institution: | Cardiovascular Research Institute, University of California, San Francisco 94143-0130. |
| |
Abstract: | We studied the effect of somatostatin on contractile responses to electrical field stimulation (EFS) in isolated ferret tracheal segments. Somatostatin (up to 10(-5) M) did not change resting tension, but it potentiated the contractile response to EFS dose dependently, with a maximum effect at 10(-6) M. Thus, at a concentration of 10(-6) M, somatostatin significantly decreased the mean log of EFS frequency producing 50% of maximum contraction from a control value of 0.52 +/- 0.07 to 0.24 +/- 0.06 (SE) Hz (P less than 0.01). The potentiating effect of somatostatin (10(-6) M) was not inhibited by hexamethonium, indomethacin, BW755C, pyrilamine, methysergide, or D,Pro2,D,Trp7,9-SP, but it was inhibited by atropine or by the somatostatin antagonist cyclo7-aminoheptanoyl-Phe-D-Trp-Lys-Thr(Bzl)]. In contrast to EFS-induced contraction, contractions produced by acetylcholine (10(-9) to 10(-3) M) were not affected by somatostatin at a concentration of 10(-6) M. These results suggest that somatostatin potentiates contractions produced by EFS via presynaptic cholinergic mechanisms and probably through a specific somatostatin receptor. |
| |
Keywords: | |
|
| 点击此处可从《Journal of applied physiology (Bethesda, Md. : 1985)》浏览原始摘要信息 |
| 点击此处可从《Journal of applied physiology (Bethesda, Md. : 1985)》下载免费的PDF全文 |
|